An anti-influenza combined therapy assessed by single cell RNA-sequencing
- PMID: 36216966
- PMCID: PMC9549038
- DOI: 10.1038/s42003-022-04013-4
An anti-influenza combined therapy assessed by single cell RNA-sequencing
Abstract
Influenza makes millions of people ill every year, placing a large burden on the healthcare system and the economy. To develop a treatment against influenza, we combined virucidal sialylated cyclodextrins with interferon lambda and demonstrated, in human airway epithelia, that the two compounds inhibit the replication of a clinical H1N1 strain more efficiently when administered together rather than alone. We investigated the mechanism of action of the combined treatment by single cell RNA-sequencing analysis and found that both the single and combined treatments impair viral replication to different extents across distinct epithelial cell types. We showed that each cell type comprises multiple sub-types, whose proportions are altered by H1N1 infection, and assessed the ability of the treatments to restore them. To the best of our knowledge this is the first study investigating the effectiveness of an antiviral therapy against influenza virus by single cell transcriptomic studies.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies.J Virol. 2020 Oct 27;94(22):e00052-20. doi: 10.1128/JVI.00052-20. Print 2020 Oct 27. J Virol. 2020. PMID: 32847855 Free PMC article.
-
In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate.Antiviral Res. 2014 Nov;111:112-20. doi: 10.1016/j.antiviral.2014.09.008. Epub 2014 Sep 20. Antiviral Res. 2014. PMID: 25245230
-
Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium.mBio. 2022 Aug 30;13(4):e0105522. doi: 10.1128/mbio.01055-22. Epub 2022 Jun 14. mBio. 2022. PMID: 35699372 Free PMC article.
-
Critical role of microRNAs in host and influenza A (H1N1) virus interactions.Life Sci. 2021 Jul 15;277:119484. doi: 10.1016/j.lfs.2021.119484. Epub 2021 Apr 13. Life Sci. 2021. PMID: 33862119 Review.
-
The use of antiviral agents for the management of severe influenza.Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.
Cited by
-
Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses.Biomed Pharmacother. 2023 Jul;163:114825. doi: 10.1016/j.biopha.2023.114825. Epub 2023 May 4. Biomed Pharmacother. 2023. PMID: 37148860 Free PMC article.
-
Development of Broad-Spectrum β-Cyclodextrins-Based Nanomaterials Against Influenza Viruses.J Med Virol. 2024 Dec;96(12):e70101. doi: 10.1002/jmv.70101. J Med Virol. 2024. PMID: 39620346 Free PMC article.
-
Research progress on miRNAs function in the interaction between human infectious viruses and hosts: A review.Biomol Biomed. 2024 Oct 17;24(6):1452-1462. doi: 10.17305/bb.2024.10821. Biomol Biomed. 2024. PMID: 39101759 Free PMC article. Review.
-
The use of single-cell RNA-seq to study heterogeneity at varying levels of virus-host interactions.PLoS Pathog. 2024 Jan 18;20(1):e1011898. doi: 10.1371/journal.ppat.1011898. eCollection 2024 Jan. PLoS Pathog. 2024. PMID: 38236826 Free PMC article. Review.
-
In Vivo Profiling of Individual Multiciliated Cells during Acute Influenza A Virus Infection.J Virol. 2022 Jul 27;96(14):e0050522. doi: 10.1128/jvi.00505-22. Epub 2022 Jul 6. J Virol. 2022. PMID: 35867557 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases